Singtel-owned hotel development site up for grabs

Similar sites in the area are rare, with the last one being sold in 2016.

A prime site in 15-33 Hill Street Singapore with a redevelopment permit has been launched for public tender, CBRE revealed.

According to a press release, the site which is owned by Singtel can be redeveloped into a hotel property.

The site comprises of two land plots with a combined land area of 39,738 sqft. The maximum allowable gross floor area (GFA) is approximately 139,084 sqft.

It is offered for sale based on a 99-year leasehold tenure and the differential premium for a change of use and lease top-up premium will apply.

CBRE Capital Markets director Galven Tan said, “Hotel development sites in the Central Area are rarely available. The last hotel site that was sold was along Cuscaden Road. The sale in 2016 achieved a land price of $2,145 psf ppr.”

The public tender will close on 13 December 2017 at at 3 p.m.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare